Latest news
Loading news…
2seventy bio
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Cambridge, Massachusetts, United States Founded 2021 501-1000 employees For Profit
2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies.
2seventy bio on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
2seventy bio was acquired by Bristol-Myers Squibb in 2025 for $286M.
Total Funding
$315M
Funding Rounds
3
Last Funding
Acquisitions
0
Monthly Visits
Contacts
242
Ticker
TSVT
NASDAQ
Patents
39
19 trademarks
About 2seventy bio
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- TSVT
- Exchange
- NASDAQ
- IPO date
- Oct 18, 2021
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 5
- Patents granted
- 39
- Trademarks
- 19
- Top patent class
- Organic Chemistry
- IT spend
- $821.74K
Company Info
- Founded
- 2021
- Employees
- 501-1000
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Sub-organizations
- 1
- News articles
- 155
- HQ
- Cambridge, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Exit date
- Oct 18, 2021
Signals & Scores
- Heat score
- Medium
- Trend (7d)
- -0.4
- Trend (30d)
- -1.3
- Trend (90d)
- -0.7
- Last leadership hire
- Feb 14, 2022
- Last layoff mention
- Jan 30, 2024
2seventy bio Funding Rounds
3 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–3 of 3Show
Page 1 / 1
2seventy bio Key People
Chief Kairos Officer
SVP, Oncology Emerging Products
Chief Technology & Manufacturing Officer
Senior Director, Oncology Commercial and Program Strategy
Chief Scientific Officer
CMO
Chief Financial Officer
242
professional contacts at 2seventy bio
Contact execs at 2seventy bio →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
FAQs about 2seventy bio
People who checked this page also checked these
Browse the full Acquirezy directory.